Jefferies upgraded PTC Therapeutics (NASDAQ: PTCT) from Underperform to Hold with a price target of $12.00 (from $18.00).Analyst Gena Wang ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE